KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBIAT (2009 - 2026)

Amgen's quarterly EBIAT came in at $1.8 billion in Q1 2026, up 5.14% year-on-year from $1.7 billion in Q1 2025, and up 36.46% quarter-over-quarter from $1.3 billion in Q4 2025.

Amgen has reported EBIAT for 18 years, with the latest figure at $1.8 billion in Q1 2026.

  • For the quarter ending Q1 2026, EBIAT rose 5.14% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $7.8 billion (up 31.47% YoY), and the FY2025 full-year result was $7.7 billion, up 88.53% from the prior year.
  • EBIAT for Q1 2026 stood at $1.8 billion, up from $1.3 billion in the prior quarter.
  • The five-year high for EBIAT was $3.2 billion in Q3 2025, with the low at -$113.0 million in Q1 2024.
  • Average EBIAT over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2022.
  • Year-over-year, EBIAT plunged 103.98% in 2024 and jumped 1630.97% in 2025.
  • Tracing AMGN's EBIAT over 5 years: stood at $1.6 billion in 2022, then sank by 52.54% to $767.0 million in 2023, then decreased by 18.25% to $627.0 million in 2024, then jumped by 112.6% to $1.3 billion in 2025, then soared by 36.46% to $1.8 billion in 2026.
  • The last three EBIAT figures came in at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIAT (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.24 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 697.00 Mn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4.24 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.02 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2.71 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 2.68 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.82 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 3.22 Bn
Jun 30, 2025 1.43 Bn
Mar 31, 2025 1.73 Bn
Dec 31, 2024 627.00 Mn
Sep 30, 2024 2.83 Bn
Jun 30, 2024 746.00 Mn
Mar 31, 2024 -113.00 Mn
Dec 31, 2023 767.00 Mn
Sep 30, 2023 1.73 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 2.84 Bn
Dec 31, 2022 1.62 Bn
Sep 30, 2022 2.14 Bn
Jun 30, 2022 1.32 Bn
Mar 31, 2022 1.48 Bn
Dec 31, 2021 1.90 Bn
Sep 30, 2021 1.88 Bn
Jun 30, 2021 464.00 Mn
Mar 31, 2021 1.65 Bn
Dec 31, 2020 1.62 Bn
Sep 30, 2020 2.02 Bn
Jun 30, 2020 1.80 Bn
Mar 31, 2020 1.83 Bn
Dec 31, 2019 1.70 Bn
Sep 30, 2019 1.97 Bn
Jun 30, 2019 2.18 Bn
Mar 31, 2019 1.99 Bn
Dec 31, 2018 1.93 Bn
Sep 30, 2018 1.86 Bn
Jun 30, 2018 2.30 Bn
Mar 31, 2018 2.31 Bn
Dec 31, 2017 -4.26 Bn
Sep 30, 2017 2.02 Bn
Jun 30, 2017 2.15 Bn
Mar 31, 2017 2.07 Bn
Dec 31, 2016 1.94 Bn
Sep 30, 2016 2.02 Bn
Jun 30, 2016 1.87 Bn
Mar 31, 2016 1.90 Bn
Dec 31, 2015 1.80 Bn
Sep 30, 2015 1.86 Bn
Jun 30, 2015 1.65 Bn
Mar 31, 2015 1.62 Bn
Dec 31, 2014 1.29 Bn
Sep 30, 2014 1.24 Bn
Jun 30, 2014 1.55 Bn
Mar 31, 2014 1.07 Bn
Dec 31, 2013 1.02 Bn
Sep 30, 2013 1.37 Bn
Jun 30, 2013 1.26 Bn
Mar 31, 2013 1.43 Bn
Dec 31, 2012 788.00 Mn
Sep 30, 2012 1.11 Bn
Jun 30, 2012 1.27 Bn
Mar 31, 2012 1.18 Bn
Dec 31, 2011 934.00 Mn
Sep 30, 2011 454.00 Mn
Jun 30, 2011 1.17 Bn
Mar 31, 2011 1.13 Bn
Dec 31, 2010 1.02 Bn
Sep 30, 2010 1.24 Bn
Jun 30, 2010 1.20 Bn
Mar 31, 2010 1.17 Bn
Dec 31, 2009 931.00 Mn
Sep 30, 2009 1.39 Bn
Jun 30, 2009 1.27 Bn
Mar 31, 2009 1.02 Bn